Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy
详细信息 查看全文
- 作者：Harun Fajkovic ; M.D.a ; harun.fajkovic@gmail.com" class="auth_mail" title="E-mail the corresponding author ; Romain Mathieu ; M.D.a ; b ; Ilaria Lucca ; M.D.a ; c ; Manuela Hiess ; M.D.a ; Nicolai Hü ; bnera ; Bashir Al Hussein Al Awamlhd ; Richard Lee ; M.D.d ; Alberto Briganti ; M.D.e ; Pierre Karakiewicz ; M.D.f ; Yair Lotan ; M.D.g ; Morgan Roupret ; M.D.h ; Michael Rink ; M.D.i ; Luis Kluth ; M.D.i ; Wolfgang Loidl ; M.D.j ; Christian Seitz ; M.D.a ; Tobias Klatte ; M.D.a ; Gero Kramer ; M.D.a ; Martin Susani ; M.D.k ; Shahrokh F. Shariat ; M.D.a ; c ; g
- 关键词：Localized prostate cancer ; Biochemical recurrence ; Lymphovascular invasion ; Radical prostatectomy
- 刊名：Urologic Oncology: Seminars and Original Investigations
- 出版年：2016
- 出版时间：May 2016
- 年：2016
- 卷：34
- 期：5
- 页码：233.e1-233.e6
- 全文大小：296 K
文摘
- •
About 10% of localized prostate cancers show lymphovascular invasion.
- •
Lymphovascular invasion is linked with adverse pathological features.
- •
Lymphovascular invasion is associated with an increased risk of biochemical recurrence.